Mineralys Therapeutics (MLYS) Stock Forecast
Analyst ratings, price targets, and earnings estimates.
MLYS Analyst Ratings
Buy
Consensus
Based on 4 analysts in the past 3 months
MLYS Stock 12 Month Forecast
$42.00
▲
(214.84%
Upside)
Highest Price Target
$42.00
(214.8%)
Average Price Target
$42.00
(214.8%)
Lowest Price Target
$30.00
(124.9%)
Based on 1 analysts in the last year
Recent Price Targets
Recommendation Trends
Analyst Estimates
Revenue Estimates
High
$-
Average
$-
Low
$-
0 analysts
Net Income Estimates
High
$-180.73M
Average
$-181.84M
Low
$-182.96M
0 analysts
EPS Estimates
High
$-3.72
Average
$-3.74
Low
$-3.77
4 analysts
Revenue Estimates
High
$9.19M
Average
$9.19M
Low
$9.19M
5 analysts
Net Income Estimates
High
$-153.39M
Average
$-195.13M
Low
$-236.87M
5 analysts
EPS Estimates
High
$-3.16
Average
$-3.82
Low
$-4.88
5 analysts
Revenue Estimates
High
$80.05M
Average
$80.05M
Low
$80.05M
5 analysts
Net Income Estimates
High
$-150.00M
Average
$-192.22M
Low
$-234.44M
5 analysts
EPS Estimates
High
$-3.09
Average
$-3.86
Low
$-4.83
4 analysts
Revenue Estimates
High
$306.13M
Average
$306.13M
Low
$306.13M
1 analysts
Net Income Estimates
High
$-85.92M
Average
$-85.92M
Low
$-85.92M
1 analysts
EPS Estimates
High
$-1.77
Average
$-1.77
Low
$-1.77
3 analysts
Revenue Estimates
High
$718.67M
Average
$718.67M
Low
$718.67M
2 analysts
Net Income Estimates
High
$110.91M
Average
$110.91M
Low
$110.91M
2 analysts
EPS Estimates
High
$2.29
Average
$2.29
Low
$2.29
2 analysts
Latest Price Target Updates
Date | Analyst | Firm | Price Target | Price When Posted | Upside |
---|---|---|---|---|---|
Apr 02, 2025 | Matthew Caufield | H.C. Wainwright | $42.00 | $14.00 | 200.0% |
Apr 02, 2024 | Richard Law | Goldman Sachs | $30.00 | $13.03 | 130.2% |
Related Metrics
Explore detailed financial metrics and analysis for MLYS.